The Ludwig Institute for Cancer Research Ltd (LICR)is a global non profit committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

In 2001, LICR and the Cancer Research Institute (CRI) in New York (USA) established the Cancer Vaccine Collaborative, an innovative partnership between two not-for-profit groups committed to understanding the immunological response to cancer and harnessing that knowledge for the development of effective therapeutic cancer therapies. More »